期刊文献+

ICU儿童感染肺炎克雷伯菌的喹诺酮类耐药株parC基因研究 被引量:1

Study on parC Gene Responsible for Chromosome-mediated Quinolone Resistance of Klebsiella pneumoniae Isolated from ICU Newborns
原文传递
导出
摘要 目的了解湖南地区新生儿感染肺炎克雷伯菌染色体介导喹诺酮类耐药基因parC基因的流行情况。方法采用PCR法对26株肺炎克雷伯菌进行parC基因检测,采用法国生物梅里埃公司生产的VITEK2-COMPACT全自动细菌鉴定检测16种抗菌药物的体外抗菌活性,PCR扩增产物经纯化后测序并进行序列分析。结果 parC基因在所有耐药株中均有第80、91位氨基酸的改变。结论本省ICU儿童感染肺炎克雷伯菌染色体介导喹诺酮类耐药基因parC基因突变情况十分普遍,监测其突变频率、位点对指导临床用药及耐药机制研究十分重要。 Objective To investigate the prevalence of infection caused by Klebsiella pneumoniae and the mutation of chromosome-mediated quinolone resistance gene,parC gene among newborns in Hunan Province.Methods PCR method was used to detect the parC gene mutation in 26 strains of Klebsiella pneumoniae.VITEK2-COMPACT automatic bacterial identification instrument was employed to detect in vitro antibacterial activity of 16 antimicrobial agents.PCR amplification products were purified,and then identified by sequence analysis.Results parC genes in all drug-resistant strains showed amino acid changes at the positions 80 and 91.Conclusions The mutation of chromosome-mediated quinolone resistance gene,parC gene is prevalent among ICU newborns in Hunan Province.Monitoring the mutation frequency and sites of parC gene plays a very important role in guiding clinical medication and researching drug resistance mechanism.
机构地区 湖南省儿童医院
出处 《实用预防医学》 CAS 2013年第3期354-356,共3页 Practical Preventive Medicine
基金 湖南省科技厅一般科技计划(2009SK3047)
关键词 肺炎克雷伯菌 喹诺酮类 抗药性 Klebsiella pneumoniae Quinolones Drug resistance
  • 相关文献

参考文献5

  • 1Munoz R, De La Campa AG. ParC subunit of DNA topoisomerase IV of Streptococcus pneurnoniae is a primary target of fluoroquinolones andcooperates with DNA gyrase A subunit in forming resistance phenotype [J ]. Antimicrob Agents Chemother, 1996, 40 : 2252 - 2257.
  • 2Yoshida H, Bogaki M, Nakamura M, et al. Quinolone resistance - de- temfining region in the DNA gyrase gyra gene of Escherlchia coli [J ]. Antimicrob Agents Chemother, 1990,34 (6) : 1271 - 1272.
  • 3徐艳,付英梅,张文莉,郭丽双,刘爱平,张凤民.肺炎克雷伯菌gyrA基因与parC基因的突变研究[J].中国微生态学杂志,2008,20(4):350-352. 被引量:9
  • 4Lau RW, Ho PL, Kao RY, et al. Molecular characterization of fluoro- quinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74 [ J ]. Antimicrob Agents Chemother, 2011, 55:608 - 614.
  • 5Billal DS, Fedorko DP, Yan SS, et al. In vitro induction and selection of fluoroquinolone- resistant mutants of Streptococcus pyogenes strains with multiple emm types[J ]. J Antirnicmb Chemother, 2007, 59:28 - 34.

二级参考文献9

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2冯仁丰.实用医学检验学[M].上海:上海科学技术出版社,2000.313.
  • 3CATTOIR V, LESPRIT P, LASCOLS C, et al. In vivo selection during ofloxacin therapy of Escherichia coli with combined to poisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid[J].J Antimicrob Chemother,2006,58 (5) : 1054-1057.
  • 4PETERSEN A, CHRISTENSEN J P, KUHNERT P, Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation[ J]. Vet Microbiol,2006,116 ( 123 ) : 120-128.
  • 5DIMRI G P, DAS H K. Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae[ J]. Nucleic Acids Res, 1990,18 ( 1 ) :151-156.
  • 6LOW D E. Quinolone resistance and its clinical relevance. In:HOOPER D C, RUBINDTEIN E, eds. Quinolone antimicrobial agents [ M ]. 3rd. Washington DC : ASM Press,2003:355-386.
  • 7YOSHIDA H, BOGAKI M, NAKAMURA M, et al. Quinolone resistancedetermining region in the DNA gyrase gyrA gene of Escherichla coli [ J ]. Antimicrob Agents Chemother, 1990,34 (6) : 1271-1272.
  • 8SCHNEIDERS T, AMYES S G, LEVY S B. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore[ J ]. Antimierob Agents Chemother, 2003,47 ( 9 ) : 2831- 2837.
  • 9马越,李景云,张新妹,许明哲,张力,胡昌勤,金少鸿.1999~2002年北京、广东、湖北和辽宁地区大肠埃希氏菌及肺炎克雷伯氏菌临床分离株耐药性比较分析[J].中国抗生素杂志,2004,29(4):226-234. 被引量:91

共引文献8

同被引文献20

  • 1尚芙蓉,蔡和伦.神经内科住院患者医院感染危险因素分析[J].湖北医药学院学报,2011,30(5):506-508. 被引量:17
  • 2高山,普珍,孙晓明,刘小康.肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J].华西药学杂志,2006,21(1):21-24. 被引量:13
  • 3Chen Y, Luo Y, Mao L, et al. A study on GvrA and ParC mu- tant in fluoroquinolone-rcsistant Kle/asiella prwumoraiae induced resistance strains in vitro[J]. Chin J Microeeol, 2009, 21 (2): 145-8.
  • 4Lau RW, Ho PL, Kao RY, et al. Molecular characterization of fluoroquinolone resistance in Mycobacteriurn tuberculosis: func- tional analysis of gyrA mutation at position 74[J]. Antimicrob A- gents Chemother, 2011, 55: 608-14.
  • 5Brisse S, Verhoe~ J. Phylogenetic diversity o[ Klebsiella pneu moniae and Klebsiella oxytoca clinical isolates revealed by ran domly amplified polymorphic DNA, gyrA and parC genes sequen eing and automated ribotypingl-J~. Int J Sys Evol Microbiol 2001, 51(3): 915-24.
  • 6Salgado CD, Ogragy N, Farr BM. Prevention and control of an timicrohial resistant infections in intensive care patients[J]. CritCare Med, 2005, 33(10): 2373-82.
  • 7Dettenkofer M, Ebner W, Els T, et al. Surveillance of nosoco mial infections in a neurology intensive care unitEJT. J Neurol 2001, 248(11) : 959-64.
  • 8Vargas M, Horcajada JP, Obach V, et al. Clinical consequences of infection in patients with acute strokeFJ~. Stroke, 2006, 37~ 461-5.
  • 9Kumar V, Sun P, Vamathevan J, et al. Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resist anee pro{iles[J]. Antimicrob Agents Chemother. 2011, 55 (9) 4267-76.
  • 10Nesar S, Shoaib MH, Rahim N, et al. Emergence of resistance to ffuoroquinolanes among gram positive and gram negative clini- cal isolates[J]. PakJ PharmSei, 2012, 25 (4): 877-81.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部